Cutler Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-800
Closed -$54K 2653
2022
Q3
$54K Sell
800
-442
-36% -$29.8K ﹤0.01% 864
2022
Q2
$39K Sell
1,242
-16,295
-93% -$512K ﹤0.01% 963
2022
Q1
$607K Buy
17,537
+17,337
+8,669% +$600K 0.03% 327
2021
Q4
$5K Sell
200
-1,000
-83% -$25K ﹤0.01% 1830
2021
Q3
$30K Buy
1,200
+55
+5% +$1.38K ﹤0.01% 1401
2021
Q2
$40K Sell
1,145
-1,555
-58% -$54.3K ﹤0.01% 1317
2021
Q1
$110K Sell
2,700
-2,215
-45% -$90.2K 0.01% 868
2020
Q4
$212K Buy
4,915
+1,415
+40% +$61K 0.01% 557
2020
Q3
$192K Buy
+3,500
New +$192K 0.01% 483
2020
Q2
Hold
0
2285
2020
Q1
Sell
-800
Closed -$63K 2244
2019
Q4
$63K Sell
800
-1,300
-62% -$102K ﹤0.01% 817
2019
Q3
$101K Sell
2,100
-1,400
-40% -$67.3K 0.01% 609
2019
Q2
$184K Buy
3,500
+2,687
+331% +$141K 0.02% 499
2019
Q1
$43K Sell
813
-9,440
-92% -$499K ﹤0.01% 882
2018
Q4
$420K Sell
10,253
-747
-7% -$30.6K 0.04% 263
2018
Q3
$418K Buy
11,000
+3,767
+52% +$143K 0.03% 388
2018
Q2
$326K Buy
+7,233
New +$326K 0.03% 411
2018
Q1
Sell
-26,584
Closed -$1.05M 2676
2017
Q4
$1.05M Buy
26,584
+26,257
+8,030% +$1.03M 0.04% 237
2017
Q3
$10K Sell
327
-6,534
-95% -$200K ﹤0.01% 1904
2017
Q2
$187K Sell
6,861
-6,024
-47% -$164K 0.01% 897
2017
Q1
$474K Buy
12,885
+11,129
+634% +$409K 0.02% 490
2016
Q4
$25K Buy
1,756
+356
+25% +$5.07K ﹤0.01% 1819
2016
Q3
$32K Sell
1,400
-200
-13% -$4.57K ﹤0.01% 1642
2016
Q2
$26K Sell
1,600
-900
-36% -$14.6K ﹤0.01% 1696
2016
Q1
$39K Buy
+2,500
New +$39K ﹤0.01% 1424